| Dr Thanuja K Hamilton, MD | |
|
204 Ark Road, Suite 206 Lmc I, Mount Laurel, NJ 08054-3100 | |
| (856) 778-4640 | |
| (856) 778-8862 |
| Full Name | Dr Thanuja K Hamilton |
|---|---|
| Gender | Female |
| Speciality | Sleep Medicine |
| Experience | 18 Years |
| Location | 204 Ark Road, Mount Laurel, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073774691 | NPI | - | NPPES |
| 102643890-0001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD440461 (Pennsylvania) | Secondary |
| 207RS0012X | Internal Medicine - Sleep Medicine | 25MA09154300 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jefferson Stratford Hospital | Stratford, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advocare Llc | 3678562188 | 288 |
News Archive
Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that it has entered into a research and development collaboration with Mayo Clinic, Rochester (USA) to develop a novel gene therapy for the treatment of chronic glaucoma.
The risk of ischemic heart disease that is associated with radiotherapy for breast cancer has substantially decreased in the last 25 years, according to a new study in the March 16 issue of the Journal of the National Cancer Institute.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
Immediate breast reconstruction following mastectomy is becoming more prevalent. However, in breast cancer patients undergoing simultaneous chemotherapy, thrombotic complications can arise that can delay or significantly modify reconstructive plans. Outcomes of cases illustrating potential complications are published in the current issue of Annals of Medicine and Surgery.
› Verified 3 days ago
| Entity Name | Advocare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770538696 PECOS PAC ID: 3678562188 Enrollment ID: O20040510001217 |
News Archive
Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that it has entered into a research and development collaboration with Mayo Clinic, Rochester (USA) to develop a novel gene therapy for the treatment of chronic glaucoma.
The risk of ischemic heart disease that is associated with radiotherapy for breast cancer has substantially decreased in the last 25 years, according to a new study in the March 16 issue of the Journal of the National Cancer Institute.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
Immediate breast reconstruction following mastectomy is becoming more prevalent. However, in breast cancer patients undergoing simultaneous chemotherapy, thrombotic complications can arise that can delay or significantly modify reconstructive plans. Outcomes of cases illustrating potential complications are published in the current issue of Annals of Medicine and Surgery.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thanuja K Hamilton, MD 204 Ark Rd, Suite 206 Lmc I, Mt Laurel, NJ 08054 Ph: (856) 778-4640 | Dr Thanuja K Hamilton, MD 204 Ark Road, Suite 206 Lmc I, Mount Laurel, NJ 08054-3100 Ph: (856) 778-4640 |
News Archive
Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that it has entered into a research and development collaboration with Mayo Clinic, Rochester (USA) to develop a novel gene therapy for the treatment of chronic glaucoma.
The risk of ischemic heart disease that is associated with radiotherapy for breast cancer has substantially decreased in the last 25 years, according to a new study in the March 16 issue of the Journal of the National Cancer Institute.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
Immediate breast reconstruction following mastectomy is becoming more prevalent. However, in breast cancer patients undergoing simultaneous chemotherapy, thrombotic complications can arise that can delay or significantly modify reconstructive plans. Outcomes of cases illustrating potential complications are published in the current issue of Annals of Medicine and Surgery.
› Verified 3 days ago
Foad I. Abandeh, MBBS Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Briggs Rd Ste 250, Mount Laurel, NJ 08054 Phone: 856-866-7466 Fax: 856-866-9088 | |
Dr. Sherin Mary Thomas Meledathu, D.O. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1001 Briggs Rd Ste 250, Mount Laurel, NJ 08054 Phone: 856-866-7466 Fax: 856-866-9088 | |
Yize Richard Wang, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 501 Fellowship Rd, Suite 101, Mount Laurel, NJ 08054 Phone: 856-642-2133 Fax: 856-642-2134 | |
Dr. Joshua Peter Desipio, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 501 Fellowship Rd, Suite 101, Mount Laurel, NJ 08054 Phone: 856-963-3572 Fax: 856-338-9211 | |
Dr. Jeffrey M Sumerson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Briggs Rd, Suite 250, Mount Laurel, NJ 08054 Phone: 856-866-7466 Fax: 856-866-9088 | |
Dr. Richard F Golden, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Briggs Rd, Suite 250, Mount Laurel, NJ 08054 Phone: 856-866-7466 Fax: 856-866-9088 |